Tocagen (NASDAQ:TOCA) will announce its earnings results after the market closes on Tuesday, November 12th. Analysts expect the company to announce earnings of ($0.68) per share for the quarter.
Tocagen (NASDAQ:TOCA) last announced its earnings results on Thursday, August 8th. The company reported ($0.72) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.76) by $0.04. The company had revenue of $0.01 million for the quarter, compared to analyst estimates of $0.50 million. Tocagen had a negative return on equity of 115.81% and a negative net margin of 300.42%. On average, analysts expect Tocagen to post $-3 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
Shares of NASDAQ TOCA opened at $0.63 on Friday. Tocagen has a 52-week low of $0.53 and a 52-week high of $14.75. The firm has a market cap of $15.43 million, a price-to-earnings ratio of -0.26 and a beta of 3.89. The business’s 50 day moving average is $0.65 and its two-hundred day moving average is $4.48. The company has a quick ratio of 4.21, a current ratio of 4.21 and a debt-to-equity ratio of 0.86.
Tocagen Company Profile
Tocagen Inc, a clinical-stage cancer-selective gene therapy company, focuses on developing and commercializing product candidates designed to activate a patient's immune system against their cancer. Its cancer-selective gene therapy platform is built on retroviral replicating vectors (RRVs), which are designed to deliver therapeutic genes into the DNA of cancer cells.
Receive News & Ratings for Tocagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tocagen and related companies with MarketBeat.com's FREE daily email newsletter.